|
WO2010036931A1
|
|
Tissue slicer
|
|
US2008293683A1
|
|
Hormone Replacement Therapy
|
|
US2008076717A1
|
|
Polypeptides for bone mineralization
|
|
ZA200603044B
|
|
DNA vaccine compositions and methods of use
|
|
US2007111958A1
|
|
Inhibition of HIV and SHIV replication with antisense interleukin-4
|
|
US2005164970A1
|
|
Method for treating prostate cancer using siRNA duplex for androgen receptor
|
|
US7488485B2
|
|
DNA vaccine compositions and methods of use
|
|
EP1643862A1
|
|
Infant formula
|
|
WO2004067762A2
|
|
Crystallized structure of type iv collagen nc1 domain hexamer
|
|
US2003013746A1
|
|
Advanced glycation end-product intermediaries and post-amadori inhibition
|
|
AU2002329643B2
|
|
Crystallized structure of type IV collagen NC1 domain hexamer
|
|
EP1551446A1
|
|
Neuroendocrine marker for cancer and method for producing same
|
|
US6783539B1
|
|
Phototriggerable, collagen-crosslinking compounds for wound closure
|
|
AU3766702A
|
|
Methods for the treatment and prevention of urinary stone disease
|
|
WO0222784A2
|
|
Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g
|
|
US6508768B1
|
|
Ultrasonic elasticity imaging
|
|
US6887682B2
|
|
Chaperonin and osmolyte protein folding and related screening methods
|
|
US6358735B1
|
|
Method for inhibiting angiogenesis and tumors with the isolated NC1 α3 chain monomer of type IV collagen
|
|
US6277074B1
|
|
Method and apparatus for motion estimation within biological tissue
|
|
AU6268199A
|
|
Live virus vaccines to protect primates from hiv-1 infection and disease
|
